| Name | Smith & Nephew |
|---|---|
| Epic | SN. |
| Isin | GB0009223206 |
| Index | UK100 UK350 |
| Industry | Medical Equipment and Services |
| Latest share price | 988.20p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £8,640.58 | Debt ratio | n/a |
| Shares in issue | 874.35 | Debt-to-equity ratio | n/a |
| P/E ratio | 17.2 | Assets / equity ratio | n/a |
| Total dividends per share | 14.40¢ | Price to book value | n/a |
| Dividend yield | 2.7 | ROCE | 7.56 |
| Dividend cover | 2.18 | EPS growth | 1 |
| Earning per share | 25.5 | 52-week high / low | 917.60p / 1,208.50p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2024-03-28 | 2024-05-22 | 23.10¢ |
| Interim | 2023-10-05 | 2023-11-01 | 14.40¢ |
| Final | 2023-03-30 | 2023-05-17 | 23.10¢ |
| Interim | 2022-09-29 | 2022-10-26 | 14.40¢ |
| Final | 2022-03-31 | 2022-05-11 | 23.10¢ |
| Interim | 2021-09-30 | 2021-10-27 | 14.40¢ |
| Final | 2021-04-01 | 2021-05-12 | 23.10¢ |
| Interim | 2020-10-01 | 2020-10-28 | 14.40¢ |
| Final | 2020-04-02 | 2020-05-06 | 23.10¢ |
| Company name | Smith & Nephew |
|---|---|
| Address | Building 5, Croxley Park, Hatters Lane, Watford, Hertfordshire, United Kingdom, WD18 8YE |
| Telephone | +44 (0)1923 477 100 |
| Website | http://www.smith-nephew.com |
| Director | Position |
|---|---|
| Dr Deepak Nath | CEO |
| Mr John Rogers | CFO |
| Mr Rupert Soames | Non-Executive Chairman |
| Mr Marc Owen | Senior Independent Director |
| Mrs Angie Risley | Independent Non-Executive Director |
| Ms Jo Hallas | Independent Non-Executive Director |
| Mr Bob White | Independent Non-Executive Director |
| Mr Jeremy (Jez) Maiden | Independent Non-Executive Director |
| Dr John Ma | Independent Non-Executive Director |
| Mr Simon Lowth | Independent Non-Executive Director |
| Ms Katarzyna Mazur Hofsaess | Independent Non-Executive Director |
| Assets $ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Reporting date | 31/12/22 | 31/12/21 | 31/12/20 |
| Intangible asssets and goodwill | 4267 | 4387 | 4414 |
| Investments and other non-current assets | 58 | 198 | 117 |
| Total non-current assets | 6110 | 6496 | 6348 |
| Inventory / work in progress | 2205 | 1844 | 1691 |
| Trade and other receivables | 1301 | 1290 | 1116 |
| Cash and equivalents | 350 | 1290 | 1762 |
| Other current assets and asset held for resale | n/a | n/a | 95 |
| Total of all assets | 9966 | 10920 | 11012 |
| Liabilities $ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Short term liabilities | 1715 | 2131 | 1688 |
| Long term liabilities | 2992 | 3221 | 4045 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 4707 | 5352 | 5733 |
| Net assets $ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Net assets | 5259 | 5568 | 5279 |
| Equity $ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Share capital | 175 | 177 | 177 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 5026 | 5225 | 4958 |
| Share premium account | 615 | 614 | 612 |
| Total equity | 5259 | 5568 | 5279 |
| Income $ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 450 | 593 | 295 |
| Pre-tax profit | 235 | 586 | 246 |